These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 27827891)
1. Factors Affecting the Baseline and Post-Treatment Scores on the Hopkins Verbal Learning Test-Revised Japanese Version before and after Whole-Brain Radiation Therapy. Saito H; Tanaka K; Kanemoto A; Nakano T; Abe E; Aoyama H Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27827891 [TBL] [Abstract][Full Text] [Related]
2. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Chang EL; Wefel JS; Hess KR; Allen PK; Lang FF; Kornguth DG; Arbuckle RB; Swint JM; Shiu AS; Maor MH; Meyers CA Lancet Oncol; 2009 Nov; 10(11):1037-44. PubMed ID: 19801201 [TBL] [Abstract][Full Text] [Related]
3. CogState computerized memory tests in patients with brain metastases: secondary endpoint results of NRG Oncology RTOG 0933. Caine C; Deshmukh S; Gondi V; Mehta M; Tomé W; Corn BW; Kanner A; Rowley H; Kundapur V; DeNittis A; Greenspoon JN; Konski AA; Bauman GS; Raben A; Shi W; Wendland M; Kachnic L J Neurooncol; 2016 Jan; 126(2):327-36. PubMed ID: 26511494 [TBL] [Abstract][Full Text] [Related]
4. Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial. Gondi V; Pugh SL; Tome WA; Caine C; Corn B; Kanner A; Rowley H; Kundapur V; DeNittis A; Greenspoon JN; Konski AA; Bauman GS; Shah S; Shi W; Wendland M; Kachnic L; Mehta MP J Clin Oncol; 2014 Dec; 32(34):3810-6. PubMed ID: 25349290 [TBL] [Abstract][Full Text] [Related]
5. Evaluating the impact of hippocampal sparing during whole brain radiotherapy on neurocognitive functions: A preliminary report of a prospective phase II study. Lin SY; Yang CC; Wu YM; Tseng CK; Wei KC; Chu YC; Hsieh HY; Wu TH; Pai PC; Hsu PW; Chuang CC Biomed J; 2015; 38(5):439-49. PubMed ID: 25994802 [TBL] [Abstract][Full Text] [Related]
6. The value of 4-month neurocognitive function as an endpoint in brain metastases trials. Onodera S; Aoyama H; Tha KK; Hashimoto N; Toyomaki A; Terae S; Shirato H J Neurooncol; 2014 Nov; 120(2):311-9. PubMed ID: 25037611 [TBL] [Abstract][Full Text] [Related]
7. Hippocampal avoidance whole-brain radiotherapy without memantine in preserving neurocognitive function for brain metastases: a phase II blinded randomized trial. Yang WC; Chen YF; Yang CC; Wu PF; Chan HM; Chen JL; Chen GY; Cheng JC; Kuo SH; Hsu FM Neuro Oncol; 2021 Mar; 23(3):478-486. PubMed ID: 32789503 [TBL] [Abstract][Full Text] [Related]
8. Impact of Apolipoprotein E Genotype on Neurocognitive Function in Patients With Brain Metastases: An Analysis of NRG Oncology's RTOG 0614. Wefel JS; Deshmukh S; Brown PD; Grosshans DR; Sulman EP; Cerhan JH; Mehta MP; Khuntia D; Shi W; Mishra MV; Suh JH; Laack NN; Chen Y; Curtis AA; Laba JM; Elsayed A; Thakrar A; Pugh SL; Bruner DW Int J Radiat Oncol Biol Phys; 2024 Jul; 119(3):846-857. PubMed ID: 38101486 [TBL] [Abstract][Full Text] [Related]
9. Hippocampal dosimetry correlates with the change in neurocognitive function after hippocampal sparing during whole brain radiotherapy: a prospective study. Tsai PF; Yang CC; Chuang CC; Huang TY; Wu YM; Pai PC; Tseng CK; Wu TH; Shen YL; Lin SY Radiat Oncol; 2015 Dec; 10():253. PubMed ID: 26654128 [TBL] [Abstract][Full Text] [Related]
10. A Randomised Phase II Trial of Hippocampal Sparing Versus Conventional Whole Brain Radiotherapy After Surgical Resection or Radiosurgery in Favourable Prognosis Patients With 1-10 Brain Metastases. Whitfield GA; Bulbeck H; Clifton-Hadley L; Edwards D; Jefferies S; Jenkinson MD; Griffin M; Handley J; Megias D; Sanghera P; Shaffer R; Short S; Wilson W Clin Oncol (R Coll Radiol); 2024 Nov; 36(11):681-689. PubMed ID: 39030085 [TBL] [Abstract][Full Text] [Related]
11. A prospective evaluation of hippocampal radiation dose volume effects and memory deficits following cranial irradiation. Ma TM; Grimm J; McIntyre R; Anderson-Keightly H; Kleinberg LR; Hales RK; Moore J; Vannorsdall T; Redmond KJ Radiother Oncol; 2017 Nov; 125(2):234-240. PubMed ID: 29128167 [TBL] [Abstract][Full Text] [Related]
12. A prospective evaluation of whole brain volume loss and neurocognitive decline following hippocampal-sparing prophylactic cranial irradiation for limited-stage small-cell lung cancer. Gui C; Chintalapati N; Hales RK; Voong KR; Sair HI; Grimm J; Duhon M; Kleinberg LR; Vannorsdall TD; Redmond KJ J Neurooncol; 2019 Sep; 144(2):351-358. PubMed ID: 31302830 [TBL] [Abstract][Full Text] [Related]
13. Post-WBRT cognitive impairment and hippocampal neuronal depletion measured by in vivo metabolic MR spectroscopy: Results of prospective investigational study. Pospisil P; Kazda T; Hynkova L; Bulik M; Dobiaskova M; Burkon P; Laack NN; Slampa P; Jancalek R Radiother Oncol; 2017 Mar; 122(3):373-379. PubMed ID: 28063694 [TBL] [Abstract][Full Text] [Related]
14. Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function. Li J; Bentzen SM; Renschler M; Mehta MP J Clin Oncol; 2007 Apr; 25(10):1260-6. PubMed ID: 17401015 [TBL] [Abstract][Full Text] [Related]
15. Association of Pretreatment Hippocampal Volume With Neurocognitive Function in Patients Treated With Hippocampal Avoidance Whole Brain Radiation Therapy for Brain Metastases: Secondary Analysis of NRG Oncology/RTOG 0933. Abraham CD; Pugh SL; Bovi JA; Gondi V; Mehta MP; Benzinger T; Owen CJ; Lo SS; Kundapur V; Brown PD; Sun AY; Howard SP; DeNittis AS; Robinson CG; Kachnic LA Adv Radiat Oncol; 2022; 7(6):100859. PubMed ID: 36420209 [TBL] [Abstract][Full Text] [Related]
16. Memory function before and after whole brain radiotherapy in patients with and without brain metastases. Welzel G; Fleckenstein K; Schaefer J; Hermann B; Kraus-Tiefenbacher U; Mai SK; Wenz F Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1311-8. PubMed ID: 18448270 [TBL] [Abstract][Full Text] [Related]
17. Pretreatment Volume of MRI-Determined White Matter Injury Predicts Neurocognitive Decline After Hippocampal Avoidant Whole-Brain Radiation Therapy for Brain Metastases: Secondary Analysis of NRG Oncology Radiation Therapy Oncology Group 0933. Bovi JA; Pugh SL; Sabsevitz D; Robinson CG; Paulson E; Mehta MP; Gondi V; Kundapur V; Shahin MS; Chao ST; Machtay M; DeNittis AS; Laack NN; Greenspoon JN; Moore KN; Huang J; Dominello MM; Kachnic LA Adv Radiat Oncol; 2019; 4(4):579-586. PubMed ID: 31673651 [TBL] [Abstract][Full Text] [Related]
18. Hippocampal avoidance whole-brain radiotherapy with simultaneous integrated boost in lung cancer brain metastases and utility of the Hopkins verbal learning test for testing cognitive impairment in Chinese patients: a prospective phase II study. Li Z; Wang J; Deng L; Zhai Y; Zhang T; Bi N; Wang J; Wang X; Liu W; Xiao Z; Chen D; Lv J; Feng Q; Wang W; Zhou Z BMC Cancer; 2024 Jul; 24(1):899. PubMed ID: 39060968 [TBL] [Abstract][Full Text] [Related]
19. Hippocampal proton MR spectroscopy as a novel approach in the assessment of radiation injury and the correlation to neurocognitive function impairment: initial experiences. Pospisil P; Kazda T; Bulik M; Dobiaskova M; Burkon P; Hynkova L; Slampa P; Jancalek R Radiat Oncol; 2015 Oct; 10():211. PubMed ID: 26474857 [TBL] [Abstract][Full Text] [Related]
20. A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases. Rades D; Dunst J; Schild SE Strahlenther Onkol; 2008 May; 184(5):251-5. PubMed ID: 18427755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]